Esophagitis and alendronate

被引：31

作者：

Liberman, UA ^{[1
]}

Hirsch, LJ ^{[1
]}

机构：

[1] MERCK RES LABS,RAHWAY,NJ 07065

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 335卷 / 14期

关键词：

D O I：

10.1056/NEJM199610033351416

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1069 / 1070

页数：2

共 5 条

[1] Esophagitis associated with the use of alendronate [J].

deGroen, PC ;

Lubbe, DF ;

Hirsch, LJ ;

Daifotis, A ;

Stephenson, W ;

Freedholm, D ;

PryorTillotson, S ;

Seleznick, MJ ;

Pinkas, H ;

Wang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1016-1021

[2] EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS [J].

LIBERMAN, UA ;

WEISS, SR ;

BROLL, J ;

MINNE, HW ;

QUAN, H ;

BELL, NH ;

RODRIGUEZPORTALES, J ;

DOWNS, RW ;

DEQUEKER, J ;

FAVUS, M ;

SEEMAN, E ;

RECKER, RR ;

CAPIZZI, T ;

SANTORA, AC ;

LOMBARDI, A ;

SHAH, RV ;

HIRSCH, LJ ;

KARPF, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1437-1443

[3]

*MERCK, 1996, FOS AL SOD

[4]

*MERCK, 1995, FOS AL SOD

[5] TESTING THE STATISTICAL CERTAINTY OF A RESPONSE TO INCREASING DOSES OF A DRUG [J].

TUKEY, JW ;

CIMINERA, JL ;

HEYSE, JF .

BIOMETRICS, 1985, 41 (01) :295-301

← 1 →